Current Edition

Drug Industry Daily

Gerresheimer will acquire Centor – higher profitability expected

? Centor is the clear market leader in the US prescription plastic vial retail market for oral drugs ? The deal extends Gerresheimer’s footprint in the primary pharm...
Continue Reading →
Drug Industry Daily

Orthobiologics Are the Future for Bone Healing

Innovations in biomaterials, graft design and other technologies have pushed these products to the forefront of the industry, says Frost & Sullivan LONDON – 21 J...
Continue Reading →
Drug GMP Report

Process Containment Technology Integrated Solutions and Project Management

As part of its overall mission of powder handling excellence DEC develops, designs and supplies turnkey process integrated containment technology solutions for both ...
Continue Reading →
Drug Industry Daily

Successfull premiere for Groninger

For Groninger this year’s Achema ended with good results and many happy faces. The market leading machine manufacturer presented various product innovations and with...
Continue Reading →
Drug Industry Daily

Simple and reliable heart valve insertion

Gerresheimer item optimizes a TAVI delivery system for minimally invasive implantation Düsseldorf/Münster/Regensburg, July 7, 2015. When heart valves get constricted...
Continue Reading →
Drug Industry Daily

Solutions to blind single and double-blind trials Melsungen, July 7, 2015

Today, the labels of investigational products are no longer used as mere carriers of specified contents, explains Frank Jäger, Managing Director of Faubel. They have...
Continue Reading →
Drug Industry Daily

PELI BIOTHERMAL REVEALS NEW SINGLE USE SHIPPER

Peli BioThermal has revealed its new single use shipper in an exclusive preview at the recent Life Science Cold Chain & Temperature Controlled Logistics event, w...
Continue Reading →
Drug Industry Daily

Crown Bioscience Strengthens Growth Strategy with Further Appointments as Global Demand Grows for PDX Models

30th June 2015 Santa Clara, CA – Crown Bioscience, Inc., a leading global drug discovery and development service company, announces five new business developments a...
Continue Reading →
Drug GMP Report

L2FU Releases its First Guide to Effective Management of Patients Lost to Follow Up in Clinical Trials

Comprehensive guide filled with tips for minimizing patient lost to follow up -a free tool for study sponsors, clinical trial sites and academic research centers. Ph...
Continue Reading →
News

ArisGlobal® Expands its Safety and Risk Management Offerings with Acquisition of Medsight Sapphire

STAMFORD, CT - 15th June 2015, ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight So...
Continue Reading →